Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Contact Us Our team is available Monday through Friday 9AM-5PM ET to assist.
Presented for research literature review only Bui V et al
To be included in the Bridge eligibility analysis, an individual was required to have coverage for Parts A, B, and D for all months of 2023, not have switched between traditional Medicare and Medicare Advantage during the year, and remain living for the entire year
Human trials of GLP-1 medications in women with PCOS have found (2): Ovulation rates of 86% in women taking GLP-1s alongside metformin - compared to 29% on metformin alone, a threefold improvement 62% of women on GLP-1s had more regular menstrual cycles, versus 28% on placebo Significant reductions in testosterone levels These are meaningful numbers for a condition where restoring ovulation and cycle regularity remains one of the challenges
US$ 21.65
US$ 27.46
US$ 29.47
US$ 26.82
US$ 20.58
US$ 26.95
